Bristol-Myers Squibb Co. has announced it will acquire Amylin Pharmaceuticals for approximately US $5.3 billion in cash. Following the completion of this acquisition, Bristol-Myers Squibb will ...

In November, Amylin announced a $1 billion partnership with Osaka, Japan–based Takeda to codevelop and commercialize obesity treatments. Takeda paid the San Diego–based biotech $75 million ...

It has been announced that following Bristol-Myers Squibb’s (BMS) successful acquisition of Amylin Pharmaceuticals, AstraZeneca (AZ) has made an initial payment of approximately US $3.2 billion ...

With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its GLP-1 and amylin receptor agonist candidates. Metsera is teaming up ...

Keybioscience AG and Eli Lilly & Co. have agreed to extend their collaboration on the development of dual amylin and calcitonin receptor agonists (DACRAs), a new class of potential treatments for ...

A new kind of weight-loss pill looks set to turbocharge dieting, as the first trial results show that it causes weight loss much faster than Ozempic. People taking the new medicine, called ...

Metabolism close metabolismAll the chemical reactions in the cells of an organism, including respiration. is the term used for all the chemical reactions that happen inside an organism's body.